Diagnostic Medical Systems S.A. (EPA:ALDMS)
France
· Delayed Price · Currency is EUR 1.020
-0.050 (-4.66%)
Apr 28, 2025, 5:13 PM CET
EPA:ALDMS Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 46.07 | 42.15 | 35.27 | 36.27 | 32.06 | Upgrade
|
| Other Revenue | 2.79 | 1.96 | 1.79 | 1.76 | 2.97 | Upgrade
|
| Revenue | 48.86 | 44.12 | 37.06 | 38.03 | 35.03 | Upgrade
|
| Revenue Growth (YoY) | 10.74% | 19.05% | -2.56% | 8.57% | 2.53% | Upgrade
|
| Cost of Revenue | 30.32 | 28.1 | 23.02 | 24.32 | 21.61 | Upgrade
|
| Gross Profit | 18.54 | 16.01 | 14.04 | 13.71 | 13.41 | Upgrade
|
| Selling, General & Admin | 15.75 | 13.91 | 11.87 | 12.14 | 13.3 | Upgrade
|
| Other Operating Expenses | 1 | 1.48 | 6.9 | 0.47 | 0.2 | Upgrade
|
| Operating Expenses | 19.33 | 17.73 | 20.9 | 14.54 | 15.77 | Upgrade
|
| Operating Income | -0.79 | -1.71 | -6.86 | -0.83 | -2.36 | Upgrade
|
| Interest Expense | -0.74 | -0.46 | -0.22 | -0.3 | -0.93 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.12 | -0.19 | 0.01 | 0 | 0.06 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.65 | -6.93 | -0.55 | -0.13 | -0.02 | Upgrade
|
| EBT Excluding Unusual Items | -3.05 | -9.28 | -7.62 | -1.26 | -3.24 | Upgrade
|
| Merger & Restructuring Charges | - | -0.8 | - | -1.39 | - | Upgrade
|
| Impairment of Goodwill | - | - | -0.89 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 0.16 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.13 | - | 2.29 | -0.11 | -1.01 | Upgrade
|
| Asset Writedown | 0.04 | 0.25 | - | - | - | Upgrade
|
| Other Unusual Items | -0.72 | - | -0.41 | - | - | Upgrade
|
| Pretax Income | -2.61 | -9.83 | -6.64 | -2.59 | -4.25 | Upgrade
|
| Income Tax Expense | 0.21 | 0 | 0.02 | - | -0 | Upgrade
|
| Earnings From Continuing Operations | -2.82 | -9.84 | -6.66 | -2.59 | -4.25 | Upgrade
|
| Earnings From Discontinued Operations | - | 4.82 | -2.31 | -2.13 | -1.29 | Upgrade
|
| Net Income to Company | -2.82 | -5.02 | -8.97 | -4.72 | -5.54 | Upgrade
|
| Minority Interest in Earnings | -0.06 | 0.07 | 2.15 | 0.85 | 0.29 | Upgrade
|
| Net Income | -2.88 | -4.95 | -6.82 | -3.88 | -5.24 | Upgrade
|
| Net Income to Common | -2.88 | -4.95 | -6.82 | -3.88 | -5.24 | Upgrade
|
| Shares Outstanding (Basic) | 20 | 17 | 16 | 16 | 16 | Upgrade
|
| Shares Outstanding (Diluted) | 20 | 17 | 16 | 16 | 16 | Upgrade
|
| Shares Change (YoY) | 17.09% | 8.33% | - | - | - | Upgrade
|
| EPS (Basic) | -0.14 | -0.28 | -0.42 | -0.24 | -0.33 | Upgrade
|
| EPS (Diluted) | -0.14 | -0.28 | -0.42 | -0.24 | -0.33 | Upgrade
|
| Free Cash Flow | 0.03 | -4.37 | -4.23 | -6.96 | -6.77 | Upgrade
|
| Free Cash Flow Per Share | 0.00 | -0.25 | -0.26 | -0.43 | -0.42 | Upgrade
|
| Gross Margin | 37.95% | 36.30% | 37.89% | 36.06% | 38.29% | Upgrade
|
| Operating Margin | -1.61% | -3.89% | -18.51% | -2.18% | -6.73% | Upgrade
|
| Profit Margin | -5.90% | -11.21% | -18.40% | -10.19% | -14.96% | Upgrade
|
| Free Cash Flow Margin | 0.06% | -9.90% | -11.42% | -18.31% | -19.34% | Upgrade
|
| EBITDA | 3.54 | 2.61 | -3.39 | 1.1 | -1.74 | Upgrade
|
| EBITDA Margin | 7.24% | 5.91% | -9.15% | 2.90% | -4.97% | Upgrade
|
| D&A For EBITDA | 4.32 | 4.32 | 3.47 | 1.93 | 0.62 | Upgrade
|
| EBIT | -0.79 | -1.71 | -6.86 | -0.83 | -2.36 | Upgrade
|
| EBIT Margin | -1.61% | -3.89% | -18.51% | -2.18% | -6.73% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.